• Series |

    This Series highlights the importance of efforts to improve diversity, equity and inclusion (DEI) in the neurology community and in neurological care to address health disparities and thereby improve global brain health.

    Image: Philip Patenall / Springer Nature Limited
  • Collection |

    The use of artificial intelligence (AI), including machine learning and large language models, is revolutionizing health care, from drug discovery and development, through to applications in the risk stratification, diagnosis, imaging, monitoring, prognostication, and pharmacological and surgical treatment of patients.

    Image: V. Summersby / Springer Nature Limited
  • Collection |

    Research into women’s health has suffered from historical neglect and lack of funding.

    Image: Lara Crow/Springer Nature Limited
  • Special |

    The COVID-19 pandemic has presented a new challenge to patients with neurological conditions and the clinicians involved in their care.

    Image: Philip Patenall
  • Collection |

    To celebrate the 15th anniversary of Nature Reviews Neurology, we present a series of Comment articles on the theme of "neurology at the crossroads", highlighting areas of neurology in which a turning point has been reached that necessitates a change in thinking. The anniversary issue also includes two Perspectives on the neurological consequences of COVID-19 and is accompanied by an online collection containing some of our most-cited articles from the past 15 years.

  • Collection |

    The 2020 Nobel Prize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer Doudna for their pioneering work in gene-editing.

    Image: Springer Nature/The Nobel Foundation/Imagesource
  • Focus |

    This Focus on neuroinflammation highlights the importance of the field across neurological subspecialties, and has been developed in collaboration with the European Academy of Neurology (EAN) to include articles written by experts who spoke at the 5th EAN Congress on the overarching theme of neuroinflammation.

    Image: Philip Patenall
  • Collection |

    The Key Advances in Medicine 2019 collection, a collaborative effort from the eight clinical Nature Reviews journals, offers expert insight into the most important discoveries made in 2018, and is an essential resource for students, physicians and clinical researchers.

  • Collection |

    The Key Advances in Neurology collection offers expert insight into the most important discoveries made each year, and is an essential resource for students, physicians and clinical researchers.

  • Milestone |

    The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.

  • Collection |

    Autoimmunity is an underlying cause of many diseases. This collection of Research, Reviews and News articles from several Nature journals covers the latest advances in genetic and epigenetic research into autoimmunity and autoimmune diseases.

    Image: Susanne Harris